Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HUMANA INCHUM · Entity 1429 | Director | January 02, 2026 | January 05, 2026 |
| JOHNSON & JOHNSONJNJ · Entity 2722 | Exec VP, WW Chair, Consumer | February 08, 2019 | February 13, 2019 |
| Mondelez International, Inc.MDLZ · Entity 2953 | Director | May 20, 2026 | May 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HUMANA INC
Report date January 02, 2026 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Humana CommonSEC Table I · non-derivative | IndirectSee Footnote | 4,127 |
Reported balance
After 2026-01-02 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-01-02 · Grant · Acquired 766 · Balance 4,127 F1: Includes 766 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. F2: Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 766 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.
F2: Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003.
JOHNSON & JOHNSON
Report date February 08, 2019 · Filed February 13, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,344 |
Ending reported balance
After 2019-02-11 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2019-02-08 · Exercise / conversion · Acquired 6,787 · Balance 22,179 F1: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting. Row 2 · 2019-02-08 · Tax withholding · Disposed 3,009 · Balance 19,170 F2: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Row 3 · 2019-02-11 · Exercise / conversion · Acquired 16,968 · Balance 36,138 F3: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Row 4 · 2019-02-11 · Grant · Acquired 2,783 · Balance 38,921 F4: Shares earned due to performance factor of 116.4% upon vesting of Performance Share Units and certification of performance results by the Board. Row 5 · 2019-02-11 · Tax withholding · Disposed 11,577 · Balance 27,344 F5: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. |
| Restricted Share UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2019-02-08 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-02-08 · Exercise / conversion · Disposed 6,787 · Balance 0 F1: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting. |
| Performance Share UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2019-02-11 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-02-11 · Exercise / conversion · Disposed 16,968 · Balance 0 F3: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting.
F2: Shares withheld for payment of taxes upon vesting of Restricted Share Units.
F3: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board.
F4: Shares earned due to performance factor of 116.4% upon vesting of Performance Share Units and certification of performance results by the Board.
F5: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board.
Mondelez International, Inc.
Report date May 20, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 69,513 |
Reported balance
After 2026-05-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 3,525 · Balance 69,513 F1: Grant of deferred stock units under the Issuer's 2024 Performance Incentive Plan. The deferred stock units are 100% vested, but receipt of the shares is deferred until the six-month anniversary of the reporting person's separation from service as a director of Mondelez International. F2: Total number of shares owned includes approximately 10,325 shares acquired through a dividend reinvestment program. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of deferred stock units under the Issuer's 2024 Performance Incentive Plan. The deferred stock units are 100% vested, but receipt of the shares is deferred until the six-month anniversary of the reporting person's separation from service as a director of Mondelez International.
F2: Total number of shares owned includes approximately 10,325 shares acquired through a dividend reinvestment program.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 20, 2026 Filed May 21, 2026 23:09 UTC | Mondelez International, Inc. MDLZ · Entity 2953 | GrantClass A Common Stock | 3,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-037474 · wk-form4_1779404954.xml · nonDerivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,513 F1 · shares: Grant of deferred stock units under the Issuer's 2024 Performance Incentive Plan. The deferred stock units are 100% vested, but receipt of the shares is deferred until the six-month anniversary of the reporting person's separation from service as a director of Mondelez International. F2 · balance_after: Total number of shares owned includes approximately 10,325 shares acquired through a dividend reinvestment program. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 18:37 UTC | HUMANA INC HUM · Entity 1429 | GrantHumana Common | 766 | $0.00 | $0.00 |
DisclosureSEC source: 0001547344-26-000002 · form4.xml · nonDerivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 4,127 F1 · balance_after: Includes 766 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. F2 · balance_after: Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003. F1 · ownership.nature: Includes 766 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. F2 · ownership.nature: Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003. Read SEC document |
| May 21, 2025 Filed May 22, 2025 20:09 UTC | Mondelez International, Inc. MDLZ · Entity 2953 | GrantClass A Common Stock | 3,009 | $0.00 | $0.00 |
DisclosureSEC source: 0001103982-25-000151 · wk-form4_1747944574.xml · nonDerivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,076 F1 · shares: Grant of deferred stock units under the Issuer's 2024 Performance Incentive Plan. The deferred stock units are 100% vested, but receipt of the shares is deferred until the six-month anniversary of the reporting person's separation from service as a director of Mondelez International. F2 · balance_after: Total number of shares owned includes 8,412 shares acquired through a dividend reinvestment program Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 15:08 UTC | HUMANA INC HUM · Entity 1429 | GrantHumana Common | 783 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000046 · form4.xml · nonDerivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 3,361 F1 · balance_after: Includes 783 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. F2 · balance_after: Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003. F1 · ownership.nature: Includes 783 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. F2 · ownership.nature: Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003. Read SEC document |
| May 22, 2024 Filed May 24, 2024 20:06 UTC | Mondelez International, Inc. MDLZ · Entity 2953 | GrantClass A Common Stock | 2,849 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-064570 · ownership.xml · nonDerivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,536 F1 · shares: Grant of deferred stock units under the Isser's 2024 Performance Incentive Plan. The deferred stock units are 100% vested, but receipt of the shares is deferred until the six-month anniversary of the reporting person's separation from service as a director of Mondelez International. F2 · balance_after: Total number of shares owned includes 6,882 shares acquired through a dividend reinvestment program. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 15:37 UTC | HUMANA INC HUM · Entity 1429 | PurchaseHumana Common | 545 | $367.09 | $200,066.07 |
DisclosureSEC source: 0001062993-24-003797 · form4.xml · nonDerivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 2,578 F3 · price: Shares acquired through open-market purchase at reported weighted average price. F1 · balance_after: Includes 430 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting 12/31/24. F2 · balance_after: Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003. F1 · ownership.nature: Includes 430 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting 12/31/24. F2 · ownership.nature: Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 16:45 UTC | HUMANA INC HUM · Entity 1429 | GrantHumana Common | 430 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-000130 · form4.xml · nonDerivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 2,033 F1 · balance_after: Includes 430 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting 12/31/24. F2 · balance_after: Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003. F1 · ownership.nature: Includes 430 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting 12/31/24. F2 · ownership.nature: Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003. Read SEC document |
| May 17, 2023 Filed May 18, 2023 20:09 UTC | Mondelez International, Inc. MDLZ · Entity 2953 | GrantClass A Common Stock | 2,461 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-030603 · doc4.xml · nonDerivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,477 F1 · shares: Grant of deferred stock units under the Issuer's Amended and Restated 2005 Performance Incentive Plan. The deferred stock units are 100% vested, but receipt of the shares is deferred until the six-month anniversary of the reporting person's separation from service as a director of Mondelez International. F2 · balance_after: Total number of shares owned includes 5,672 shares acquired through a dividend reinvestment program. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 17:42 UTC | HUMANA INC HUM · Entity 1429 | GrantHumana Common | 380 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-000126 · form4.xml · nonDerivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,603 F1 · balance_after: Includes 380 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting 12/31/23. F2 · balance_after: Due to scrivener's error, 375 shares purchased and reported on 3/8/21 were inadvertently not carried forward on previous Form 4. Shares reported reflect accurate holdings. F3 · ownership.nature: Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003. Shares were incorrectly reported as Direct holdings on previous Form 4. Read SEC document |
| May 18, 2022 Filed May 20, 2022 12:33 UTC | Mondelez International, Inc. MDLZ · Entity 2953 | GrantClass A Common Stock | 3,118 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030824 · doc4.xml · nonDerivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,934 F1 · shares: Grant of deferred stock units under the Issuer's Amended and Restated 2005 Performance Incentive Plan. The deferred stock units are 100% vested, but receipt of the shares is deferred until the six-month anniversary of the reporting person's separation from service as a director of Mondelez International. F2 · balance_after: Total number of shares owned includes 4,590 shares acquired through a dividend reinvestment program. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 14:50 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 436 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-005044 · form4.xml · derivative · entry 2 Mesquita Jorge S. · CIK 0001547344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 436 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F1 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F2 · derivative.exercise_date: Initial award of $165,000 worth of restricted stock units pursuant to the annual Director's Fee Program. 100% of the award will vest on 2/17/2022 and forfeited in its entirety if service is less than one year. F2 · derivative.expiration_date: Initial award of $165,000 worth of restricted stock units pursuant to the annual Director's Fee Program. 100% of the award will vest on 2/17/2022 and forfeited in its entirety if service is less than one year. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 14:50 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 436 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-005044 · form4.xml · nonDerivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 848 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · balance_after: Includes 412 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting 12/31/22. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 14:28 UTC | HUMANA INC HUM · Entity 1429 | GrantHumana Common | 412 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-000502 · form4.xml · nonDerivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 412 F3 · security: Includes 412 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting 12/31/22. F3 · ownership.direct: Includes 412 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting 12/31/22. Read SEC document |
| May 19, 2021 Filed May 21, 2021 20:13 UTC | Mondelez International, Inc. MDLZ · Entity 2953 | GrantClass A Common Stock | 3,048 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034889 · doc4.xml · nonDerivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,921 F1 · shares: Grant of deferred stock units under the Issuer's Amended and Restated 2005 Performance Incentive Plan. The deferred stock units are 100% vested, but receipt of the shares is deferred until the six-month anniversary of the reporting person's separation from service as a director of Mondelez International. F2 · balance_after: Total number of shares owned includes 3,695 shares acquired through a dividend reinvestment program. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 16:00 UTC | HUMANA INC HUM · Entity 1429 | PurchaseHumana Common | 375 | $403.37 | $151,263.19 |
DisclosureSEC source: 0000049071-21-000064 · edgar.xml · nonDerivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 375 F4 · price: All shares purchased at reported price. F3 · ownership.nature: Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 15:51 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 436 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-21-000040 · edgar.xml · derivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 436 Underlying: Humana Common · 436 shares Expires not disclosed F1 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F1 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F2 · derivative.exercise_date: Initial award of $165,000 worth of restricted stock units pursuant to the annual Director's Fee Program. 100% of the award will vest on 2/17/2022 and forfeited in its entirety if service is less than one year. F2 · derivative.expiration_date: Initial award of $165,000 worth of restricted stock units pursuant to the annual Director's Fee Program. 100% of the award will vest on 2/17/2022 and forfeited in its entirety if service is less than one year. Read SEC document |
| May 13, 2020 Filed May 14, 2020 23:44 UTC | Mondelez International, Inc. MDLZ · Entity 2953 | GrantClass A Common Stock | 3,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029357 · doc4.xml · nonDerivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,048 F1 · shares: Grant of deferred stock units under the Issuer's Amended and Restated 2005 Performance Incentive Plan. The deferred stock units are 100% vested, but receipt of the shares is deferred until the six-month anniversary of the reporting person's separation from service as a director of Mondelez International. F2 · balance_after: Total number of shares owned includes 2,870 shares acquired through a dividend reinvestment program. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:09 UTC | Mondelez International, Inc. MDLZ · Entity 2953 | GrantClass A Common Stock | 3,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-030858 · doc4.xml · nonDerivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,827 F1 · shares: Grant of deferred stock units under the Issuer's Amended and Restated 2005 Performance Incentive Plan. The deferred stock units are 100% vested, but receipt of the shares is deferred until the six-month anniversary of the reporting person's separation from service as a director of Mondelez International. F2 · balance_after: Total number of shares owned includes 2,181 shares acquired through a dividend reinvestment program. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionPerformance Share Units · Derivative | 16,968 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002350 · doc4.xml · derivative · entry 7 Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,968 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. F3 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 11,577 | $131.94 | $1,527,469.38 |
DisclosureSEC source: 0001225208-19-002350 · doc4.xml · nonDerivative · entry 5 Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,344 F5 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantCommon Stock | 2,783 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002350 · doc4.xml · nonDerivative · entry 4 Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,921 F4 · shares: Shares earned due to performance factor of 116.4% upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 16,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002350 · doc4.xml · nonDerivative · entry 3 Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,138 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 02:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionRestricted Share Units · Derivative | 6,787 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002350 · doc4.xml · derivative · entry 6 Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,787 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 02:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 3,009 | $132.00 | $397,188.00 |
DisclosureSEC source: 0001225208-19-002350 · doc4.xml · nonDerivative · entry 2 Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,170 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 02:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 6,787 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002350 · doc4.xml · nonDerivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,179 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting. Read SEC document |
| May 16, 2018 Filed May 18, 2018 13:05 UTC | Mondelez International, Inc. MDLZ · Entity 2953 | GrantClass A Common Stock | 4,429 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-031272 · doc4.xml · nonDerivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,774 F1 · shares: Grant of deferred stock units under the Issuer's Amended and Restated 2005 Performance Incentive Plan. The deferred stock units are 100% vested, but receipt of the shares is deferred until the six-month anniversary of the reporting person's separation from service as a director of Mondelez International. F2 · balance_after: Total number of shares owned includes 1,505 shares acquired through a dividend reinvestment program. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:13 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantRestricted Share Units · Derivative | 2,487 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002950 · doc4.xml · derivative · entry 2 Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,487 Underlying: Common Stock · 2,487 shares Expires not disclosed F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F2 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:13 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantEmployee Stock Options (Right to Buy) · Derivative | 49,566 | $0.00 Strike: $129.51 | $0.00 |
DisclosureSEC source: 0001225208-18-002950 · doc4.xml · derivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,566 Underlying: Common Stock · 49,566 shares Expires 2028-02-12 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 21:21 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionRestricted Share Units · Derivative | 32,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002184 · doc4.xml · derivative · entry 3 Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 32,688 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 2, 2015, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. F3 · derivative.expiration_date: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 2, 2015, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 21:21 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 17,296 | $138.88 | $2,402,068.48 |
DisclosureSEC source: 0001225208-18-002184 · doc4.xml · nonDerivative · entry 2 Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,392 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 21:21 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 32,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002184 · doc4.xml · nonDerivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| May 17, 2017 Filed May 18, 2017 21:12 UTC | Mondelez International, Inc. MDLZ · Entity 2953 | GrantClass A Common Stock | 3,902 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-033646 · doc4.xml · nonDerivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,852 F1 · shares: Grant of deferred stock units under the Issuer's Amended and Restated 2005 Performance Incentive Plan. The deferred stock units are 100% vested, but receipt of the shares is deferred until the six-month anniversary of the reporting person's separation from service as a director of Mondelez International. F2 · balance_after: Total number of shares owned includes 1,012 shares acquired through a dividend reinvestment program. Read SEC document |
| February 13, 2017 Filed Feb 16, 2017 11:02 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantRestricted Share Units · Derivative | 7,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003499 · doc4.xml · derivative · entry 2 Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,106 Underlying: Common Stock · 7,106 shares Expires not disclosed F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F2 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 13, 2017 Filed Feb 16, 2017 11:02 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantEmployee Stock Options (Right to Buy) · Derivative | 84,454 | $0.00 Strike: $115.67 | $0.00 |
DisclosureSEC source: 0001225208-17-003499 · doc4.xml · derivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,454 Underlying: Common Stock · 84,454 shares Expires 2027-02-13 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.